Pfizer Covid vaccine reaches key safety milestone, to seek emergency US FDA approval

The Print | Nov 18, 2020 at 4:50 AM
  • Pfizer Inc. Chief Executive Officer Albert Bourla said that a key safety milestone had been reached in the study of its Covid-19 vaccine, and the drugmaker is now preparing to seek an emergency-use authorization from U.S. regulators.
  • Moderna expects to get the safety data it needs by the end of the month, allowing it to file for emergency clearance in the coming weeks.